Clinical Trial Update: Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial update for inhaled BMD003 (CFTR mRNA) in Chinese cystic fibrosis patients aged 12 years and older; the study is not yet recruiting and aims to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• BMD003 (CFTR mRNA) (CFTR mRNA)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cystic Fibrosis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING